Effects of Pork Protein on Recovery Following Simulated Fireground Activity

Conditions: Exercise Recovery; Physical Performance Parameters; Muscle Damage; Cognition; Blood Biomarkers; Stress
Interventions: Other: Pork-Based Protein Ready-to-Eat Meals; Other: Plant-Based Protein Ready-to-Eat Meals; Other: Carbohydrate-Focused Lower-Protein Ready-to-Eat Meals
Sponsors: Sam Houston State University; National Pork Board
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 16, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Prehabilitation for Improving Outcomes in Breast Cancer Patients Undergoing Neoadjuvant Systemic Treatment and Surgery

Conditions: Breast Carcinoma
Interventions: Other: Aerobic Exercise; Procedure: Bioelectric Impedance Analysis; Other: Consultation; Other: Educational Intervention; Other: Electronic Health Record Review; Other: Nutritional Intervention; Other: Physical Performance Testing; Behavioral: Psychosocial Care; Other: Questionnaire Administration; Other: Referral; Other: Resistance Training; Procedure: Spiritual Therapy; Procedure: Tailored Intervention
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 16, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Effects of Use of a Connected Pillbox On Medication Adherence

Conditions: Diabetes Mellitus; Hypertension; Hyperlipidemia
Interventions: Device: Pre-filled trays
Sponsors: University of Pennsylvania; TowerView Health
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 16, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With
Conditions: Tumor Infiltrating Lymphocyte; CD8-PET; Advanced Melanoma

Interventions: Drug: Crefmirlimb; Device: PET/CT imaging

Sponsors: M.D. Anderson Cancer Center; ImaginAb, Inc.

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 16, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
10 Degree C Static Storage in Heart Transplantation

Conditions: Transplant, Failure, Heart; Heart Transplant; Heart Failure
Interventions: Device: 10 degree C Static Storage Cooler
Sponsors: John Trahanas
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Conditions: Esophageal Cancer; Advanced Esophageal Cancer; Gastric Cancer; Advanced Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Advanced Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma; Gastroesophageal Junction Cancer

Interventions: Biological: Intratumoral 2141-V11; Biological: Nivolumab; Drug: Fluoropyrimidine

Sponsors: Memorial Sloan Kettering Cancer Center; Rockefeller University

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2026Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
CREO – Microwave Ablation Feasibility Study

Conditions: Pancreatic Cancer; Liver Cancer (Locally Advanced or Metastatic); Pancreatic Cancer Non-resectable; Pancreatic Cancer Stage III; Pancreatic Cancer Stage IV; Liver Cancer Stage IV; Liver Cancer Stage IIIa; Liver Cancer Stage IIIb; Liver Cancer Stage IIIc
Interventions: Device: EUS-Guided MWA Device
Sponsors: Banner Health; Creo Medical Limited; CreoMed, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

Conditions: Congenital Adrenal Hyperplasia
Interventions: Drug: Chronocort®; Drug: Standard Care
Sponsors: Neurocrine UK Limited; National Institutes of Health (NIH)
Withdrawn

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: CagriSema
Sponsors: Novo Nordisk A/S
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Conditions: Platinum-sensitive Relapsed Epithelial Ovarian Cancer; Platinum-sensitive Relapsed Fallopian Tube Cancer; Platinum-sensitive Relapsed Primary Peritoneal Cancer

Interventions: Drug: Torvutatug samrotecan; Drug: Bevacizumab

Sponsors: AstraZeneca; GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT); Ventana Medical Systems, Inc

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine